Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Merck & Co Inc MRK

Healthcare
Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for... see more

Recent & Breaking News (NYSE:MRK)

3 Reasons To Consider Investing In RXi Pharmaceuticals

Accesswire October 16, 2013

Merck Presents New Pharmacokinetic Data on ISENTRESS® (raltegravir) at 14th European AIDS Conference

Business Wire October 16, 2013

Results of Phase II PRECEDENT Trial for Investigational Folate Receptor Therapy Vintafolide in Patients with Platinum-Resistant Ovarian Cancer Published in Journal of Clinical Oncology

Business Wire October 14, 2013

Systemic Versus Non-Systemic Diabetes Drugs

Accesswire October 7, 2013

Five Star Equities Issues New Research Reports on ACT, LXRX, MRK and WAG

Accesswire October 2, 2013

Interim Data for Merck's MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Previously Treated Patients with Non-Small Cell Lung Cancer to be Presented at 15th World Conference on Lung Cancer

Business Wire October 1, 2013

Data from Merck's Investigational Hepatitis C Treatment Portfolio to be Presented at the 64th American Association for the Study of Liver Diseases Annual Meeting

Business Wire October 1, 2013

Merck Updates Plans for Headquarters Move in New Jersey

Business Wire October 1, 2013

Merck Announces Global Initiative to Sharpen Commercial and R&D Focus

Business Wire October 1, 2013

Merck Animal Health Proudly Supports Vaccination Programs Targeted at Reducing Disease in Domestic Pets

Business Wire September 28, 2013

Merck to Hold Third-Quarter 2013 Sales and Earnings Conference Call on October 28

Business Wire September 27, 2013

New Breakthroughs Bolster RNAi Stocks

Accesswire September 24, 2013

Merck Receives Complete Response Letter for Investigational Medicine Sugammadex Sodium Injection

Business Wire September 23, 2013

Merck and AstraZeneca Enter License Agreement for Investigational Oral WEE1 Kinase Inhibitor Therapy for Cancer

Business Wire September 11, 2013

Merck to Present at the Morgan Stanley Global Healthcare Conference

Business Wire September 10, 2013

New Survey of People Living with HIV Shows Desire for Greater Doctor-Patient Dialogue about Treatment and Disease Impact

PR Newswire September 9, 2013

Merck Announces FDA Acceptance of New Drug Application for Investigational Fertility Treatment

Business Wire September 9, 2013

Calvert Social Index Actions

Business Wire August 30, 2013

Profitable Trading Secrets Revealed in MRK, M, MOS and PHM

Marketwired August 16, 2013

Start Making Profits Now With LUV, ATVI, MCP and MRK

Marketwired August 15, 2013